Ratnakar Securities Pvt. Ltd.

ALBERT DAVID LTD.

NSE : ALBERTDAVDBSE : 524075ISIN CODE : INE155C01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE799.300 (0 %)

PREV CLOSE ( ) 799.30

OPEN PRICE ( ) 802.95

BID PRICE (QTY) 798.05 (1)

OFFER PRICE (QTY) 799.95 (1)

VOLUME 195

TODAY'S LOW / HIGH ( )795.00 810.60

52 WK LOW / HIGH ( )763.9 1752.95

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1938

Management Info

Arun Kumar Kothari - Chairman Umesh Manohar Kunte - Managing Director

Registered Office

Address D Block, 3rd Floor,Gillander House 8,Netaji Subhas Road,
Kolkata,
West Bengal-700001

Phone 033 22628436 / 8456 / 8492

Email albertdavid@adlindia.in

Website www.albertdavidindia.com

Registrars Details

Maheshwari Datamatics Pvt Ltd

23 RN Mukherjee Road, ,5th Floor (Old Address: 6 Mangaoe Lane 2nd Floor),,kokata

Listing : BSE, NSE

NEWS

27Feb Albert David informs about disclosure
Albert David has informed that the exchange has received the disclosure..

19Sep Albert David informs about closure of
In terms the SEBI (Prohibition of Insider Trading) Regulations, 2015, as..

23Aug Albert David informs about details of
Albert David has informed under Regulation 39(3) of the SEBI (Listing Ob..

15Jul Albert David informs about compliance
Albert David has informed about Compliance Certificate as received from..

23Apr Albert David informs about notice to s
In terms of Regulation 30 of the Securities and Exchange Board of India..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	-103.28	172.01
Gross Profit	-118.09	252.28
Operating Profit	-98.59	326.07
Net Sales	748.93	3457.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 9601.45 (2.86%)	M.Cap ( in Cr)23849.75
Abbott India (BSE) 31252.55 (0.62%)	M.Cap ( in Cr)66399.93
Glaxosmithkline Phar (BSE) 3380.00 (4.85%)	M.Cap ( in Cr)56259.74
Jenburkt Pharma (BSE) 1260.00 (10.20%)	M.Cap ( in Cr)519.84
Onesource Specialty (BSE) 1951.35 (4.46%)	M.Cap ( in Cr)21913.35

Shareholding Pattern

	PROMOTERS	62.24%
	NON-INSTITUTION	35.11%
	FI/BANKS/INSURANCE	1.62%
	MUTUAL FUNDS/UTI	0.01%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

ALBERT DAVID LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES